World's Best Scientists 2026 revealed!
Award Badge
Immunology
Norway
2026

D-Index & Metrics

Immunology

D-Index
101
Citations
41966
World Ranking
694
National Ranking
4

Medicine

D-Index
101
Citations
42001
World Ranking
7906
National Ranking
31

Pål Aukrust publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pål Aukrust sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 730 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pål Aukrust D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pål Aukrust sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 101 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Norway Leader Award
  • 2025 - Research.com Immunology in Norway Leader Award
  • 2022 - Research.com Immunology in Norway Leader Award

Overview

Pål Aukrust is affiliated with Oslo University Hospital in Norway and has contributed extensively to the field of medicine, with a particular focus on immunology, infectious diseases, and cardiovascular medicine. Their research spans several interconnected subfields including molecular biology and epidemiology.

Themes integral to their work encompass COVID-19 clinical research studies, long-term effects of COVID-19, and SARS-CoV-2 and COVID-19 research. Additional areas of specialization include adipokines, inflammation, metabolic diseases, cardiac fibrosis and remodeling, atherosclerosis and cardiovascular diseases, as well as acute myocardial infarction research.

Aukrust has published frequently in several scientific journals, with notable recurring publication venues being:

  • Frontiers in Immunology
  • Journal of Infection
  • Scientific Reports
  • Journal of Internal Medicine
  • SSRN Electronic Journal

Their recent published papers highlight a focus on COVID-19 treatments and immune response markers. Among these publications are:

  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results, 2020, New England Journal of Medicine
  • Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses, 2022, The Lancet
  • Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure, 2020, Journal of Infection
  • Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19, 2021, Annals of Internal Medicine
  • Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19, 2020, Scientific Reports

Collaborative efforts with other researchers form a considerable part of Aukrust's academic profile. Frequent co-authors include:

  • Thor Ueland
  • Bente Halvorsen
  • Tuva B. Dahl
  • Marius Trøseid
  • Anne Ma Dyrhol-Riise

This collaborative network reflects a multidisciplinary approach within the broader scope of immunology and cardiovascular research. Aukrust's work contributes to the understanding of inflammatory responses and cardiovascular implications in infectious diseases, especially in the context of the COVID-19 pandemic.

Best Publications

  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

    Hongchao Pan;Richard Peto;Ana-Maria Henao-Restrepo

  • Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes

    Pål Aukrust;Fredrik Müller;Thor Ueland;Trude Berget

  • Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

    John Willy Haukeland;Jan Kristian Damås;Zbigniew Konopski;Else Marit Løberg

  • The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

    Øystein Sandanger;Trine Ranheim;Leif Erik Vinge;Leif Erik Vinge;Marte Bliksøen

  • Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure

    Pål Aukrust;Thor Ueland;Fredrik Müller;Arne K. Andreassen

  • Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

    Lars Gullestad;Halfdan Aass;Jan G. Fjeld;Lisbeth Wikeby

  • The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

    Martin Kummen;Kristian Holm;Jarl Andreas Anmarkrud;Ståle Nygård;Ståle Nygård

  • Inflammatory cytokines in heart failure: mediators and markers.

    Lars Gullestad;Thor Ueland;Leif Erik Vinge;Alexandra Finsen

  • Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.

    Ola Kleveland;Gabor Kunszt;Gabor Kunszt;Marte Bratlie;Marte Bratlie;Thor Ueland

  • Systemic inflammation in heart failure--the whys and wherefores.

    Arne Yndestad;Jan Kristian Damås;Erik Oie;Thor Ueland

  • Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.

    Jan Cato Holter;Jan Cato Holter;Soeren Pischke;Soeren Pischke;Eline de Boer;Eline de Boer;Andreas Lind

  • Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint)

    Pan Hongchao;Richard Peto;Ana-Maria Henao-Restrepo;Marie-Pierre Preziosi

  • Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.

    Kaspar Broch;Kaspar Broch;Anne Kristine Anstensrud;Sindre Woxholt;Kapil Sharma

  • Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

    Arne Yndestad;Linn Landrø;Thor Ueland;Christen P. Dahl

  • NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis

    Geena Paramel Varghese;Lasse Folkersen;Rona J. Strawbridge;Bente Halvorsen

  • Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

    Lars Gullestad;Pål Aukrust;Thor Ueland;Terje Espevik

  • Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.

    Knut A Hestad;Sverre Tønseth;Charlotte D Støen;Thor Ueland

  • Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure

    Thor Ueland;Arne Yndestad;Erik Øie;Geir Florholmen

  • CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice

    Peder S. Olofsson;Leif Å. Söderström;Dick Wågsäter;Yuri Sheikine

  • Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

    Asbjørg Stray-Pedersen;Hanne Sørmo Sorte;Pubudu Samarakoon;Tomasz Gambin;Tomasz Gambin

  • Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes

    Torbjørn Omland;Thor Ueland;Anna M. Jansson;Anita Persson

  • Chemokines and Cardiovascular Risk

    Pål Aukrust;Bente Halvorsen;Arne Yndestad;Thor Ueland

Frequent Co-Authors

Thor Ueland
Thor Ueland University of Oslo
Lars Gullestad
Lars Gullestad Oslo University Hospital
Arne Yndestad
Arne Yndestad Oslo University Hospital
Bente Halvorsen
Bente Halvorsen University of Oslo
Stig S. Frøland
Stig S. Frøland University of Oslo
Tom Eirik Mollnes
Tom Eirik Mollnes Oslo University Hospital
Fredrik Müller
Fredrik Müller University of Oslo
Rolf K. Berge
Rolf K. Berge University of Bergen
John Kjekshus
John Kjekshus University of Oslo
Sverre Holm
Sverre Holm University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open additional career opportunities. Nursing, particularly advanced practice roles, often intersects with immunological research and patient care. If you're considering a transition or complementary degree, programs like what is the easiest np program can help identify streamlined paths to becoming a Nurse Practitioner (NP).

Specializations such as Psychiatric Mental Health Nurse Practitioner (PMHNP) offer focused clinical training relevant to immune-related mental health conditions. To find quality education in this niche, prospective students frequently look for top psychiatric mental health nurse practitioner programs online that emphasize strong clinical placement rates, ensuring hands-on experience.

Cost remains a crucial factor when enrolling in these programs. Fortunately, there are resources listing affordable pmhnp programs that balance quality education with reasonable tuition fees to reduce financial barriers.

Beyond degree selection, understanding potential career outcomes is vital. Knowing how much do dnps make in various states can guide decision-making and highlight the return on investment for Doctor of Nursing Practice (DNP) graduates pursuing immunology-adjacent healthcare careers.

Best Scientists Citing Pål Aukrust

Trending Scientists

Recently Published Articles